The Multinational medical biotechnology industry in Taiwan was affected by the overall government health care resources and directions. In addition, these industries in Taiwan are severely constraints by capabilities and technology in research and development simply because of huge barrier inherited in the medical biotechnology industry in Taiwan. Situation can only be improves by accelerating the improvement in R&D capabilities as well as innovative products offers.
To clear see the overall picture of how the medical biotechnology industry operates in Taiwan, most of the state- of- the-art medical supplies or drug were manufactured by multinational company due to heavy resources needed, in another word; they would like to find the appropriate distribution channel to represents their business in Taiwan in order to turns their investments into success. The ways or evaluation criteria in term of how they selects the most appropriate representations would accord to some key factors. In this study, will use ANP method and interview of several Chief executive officer, or managers to find the key factors for discussion.
Owing to the accumulation of 20 plus years of experience in running a company within medical biotechnology industry, I can truly validated the “crucial “thoughts’’ process in running the company ,and keep its survived with healthy leverage. However, counting on practical is important but that would not be sufficient without scientific proof. In this study, I have also included the valuables view of a few experts in the similar industry. The successful finding of this research could possibly add values by assisting more companies to think how they can survive, and how much value they have in the country of Taiwan; As a result, Taiwan government would invest more resources to accelerate and improves the development on medical biotechnology.
